Big Pharma cancer treatment: $606,000+ for one yea
Post# of 36728
Posted On: 11/09/2013 10:43:28 PM
Big Pharma cancer treatment: $606,000+ for one year life extension at the outside. The economics alone of Canna-Loz (Simpson) and Canna-Loz (Dharmanol) treatment will drive the market to SK licensed products in droves. Canna-Loz may debut in less than 2weeks; Dharmanol within 30 days. This could be seismic.
New York Magazine: "The Cost of Living. New drugs could extend cancer patients’ lives—by days at a cost of thousands and thousands of dollars, prompting some doctors to refuse to use them."
http://nymag.com/news/features/cancer-drugs-2013-10/
"On August 3, 2012, the Food and Drug Administration approved a new cancer drug called Zaltrap as a safe and effective treatment for patients with advanced colon cancer. The approval was based on a large-scale clinical trial that showed that Zaltrap, given in combination with three previously approved drugs to patients who had failed initial therapy, extended median overall survival by 42 days. "
"I want to emphasize it’s not that we can have a year of life saved for $303,000 . That’s probably less than half of what the actual cost would be when you factor in everything .” Zaltrap, he (Dr. Saltz) figured, was probably going to be in the same range."
"An estimated 1.7 million Americans will be diagnosed with cancer this year , according to the National Cancer Institute, and more than 580,000 people will die from some form of malignancy.
"In 2012, the overall market for “oncologics” reached nearly $26 billion a year in the U.S. alone, and annual global sales are projected to total $85 billion by 2016 , according to the IMS Institute for Health Informatics." (EvaluatePharma estimates $84 billion for current global "oncologics" market.)
New York Magazine: "The Cost of Living. New drugs could extend cancer patients’ lives—by days at a cost of thousands and thousands of dollars, prompting some doctors to refuse to use them."
http://nymag.com/news/features/cancer-drugs-2013-10/
"On August 3, 2012, the Food and Drug Administration approved a new cancer drug called Zaltrap as a safe and effective treatment for patients with advanced colon cancer. The approval was based on a large-scale clinical trial that showed that Zaltrap, given in combination with three previously approved drugs to patients who had failed initial therapy, extended median overall survival by 42 days. "
"I want to emphasize it’s not that we can have a year of life saved for $303,000 . That’s probably less than half of what the actual cost would be when you factor in everything .” Zaltrap, he (Dr. Saltz) figured, was probably going to be in the same range."
"An estimated 1.7 million Americans will be diagnosed with cancer this year , according to the National Cancer Institute, and more than 580,000 people will die from some form of malignancy.
"In 2012, the overall market for “oncologics” reached nearly $26 billion a year in the U.S. alone, and annual global sales are projected to total $85 billion by 2016 , according to the IMS Institute for Health Informatics." (EvaluatePharma estimates $84 billion for current global "oncologics" market.)
(0)
(0)SK3 Group Inc. (SKTO) Stock Research Links
Scroll down for more posts ▼